跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INCREXXA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INCREXXA
Authorized
STANDARD
INCREXXA
ELANCO CANADA LIMITED
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
362f67e8a10ad345
Company
ELANCO CANADA LIMITED
Type
Standard
Approval Details
Approval Id
362f67e8a10ad345
Drug Approval Canada Name
INCREXXA
Product Name
INCREXXA
Status
Marketed
Status Date
2021-09-16
Original Market Date
2021-09-16
Drug Class
Veterinary
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intramuscular
Schedule
Prescription
Atc Original
Not Applicable
Aig Number
0151667001
Company Name
ELANCO CANADA LIMITED
Company Address
401 1919 Minnesota Court Mississauga Ontario Canada L5N 0C9
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
362f67e8a10ad345
Type
Standard
Back to Health Canada Approvals